Extraordinarily elevated serum levels of CA 19-9 and rapid decrease after successful therapy: a case report and...

Area of Science:

• Oncology
• Gastroenterology
• Clinical Chemistry

Background:

• Carbohydrate antigen 19-9 (CA 19-9) is a serum marker primarily used for pancreatic and biliary cancers.
• Elevated CA 19-9 levels (>1,000 U/ml) suggest digestive malignancy with high specificity for pancreatic cancer (>99%).
• However, benign conditions like pancreatitis and liver cirrhosis can also cause false-positive elevations.

Observation:

• A patient presented with cholelithiasis, choledocholithiasis, and acute cholangitis.
• This patient exhibited exceptionally high serum levels of CA 19-9, measuring 9586 IU/ml.
• The CA 19-9 levels demonstrated a rapid decrease following successful treatment of the acute cholangitis.

Findings:

• The study highlights a case of extremely elevated CA 19-9 in the context of acute cholangitis, a benign condition.
• The observed CA 19-9 levels far exceeded typical elevations seen in many malignancies.
• The rapid normalization of CA 19-9 post-treatment underscores its dynamic nature and response to resolving inflammation.

Implications:

• This case emphasizes the importance of considering benign inflammatory conditions, such as acute cholangitis, in the differential diagnosis of significantly elevated CA 19-9.
• It suggests that extremely high CA 19-9 levels may not always indicate malignancy and can be influenced by severe biliary tract inflammation.
• Further investigation into the mechanisms driving such marked CA 19-9 elevation in benign diseases may refine its diagnostic utility.